| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | KATNAL2 SPAST EIF4A3 MCM6 KATNAL1 STARD9 ATP2C2 DYNLRB2 DYNLRB1 DNA2 DHX29 DNAH3 KIF23 DNAH10 TOR2A ANXA5 CHD9 ATP9A HELQ TRAP1 ACIN1 DNAH11 | 2.04e-05 | 614 | 261 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KATNAL2 SPAST EIF4A3 MCM6 KATNAL1 ATP2C2 DNA2 DHX29 DNAH3 KIF23 DNAH10 TOR2A CHD9 ATP9A HELQ TRAP1 ACIN1 DNAH11 | 2.19e-05 | 441 | 261 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.57e-05 | 70 | 261 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.14e-04 | 37 | 261 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule severing ATPase activity | 1.75e-04 | 9 | 261 | 3 | GO:0008568 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KATNAL2 SPAST GBP7 EIF4A3 GARS1 RAB22A MCM6 KATNAL1 ATP2C2 DNA2 DHX29 GNL1 EFL1 DNAH3 KIF23 DNAH10 CILP TOR2A CHD9 ATP9A HELQ TRAP1 ACIN1 DNAH11 | 2.86e-04 | 839 | 261 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KATNAL2 SPAST GBP7 EIF4A3 GARS1 RAB22A MCM6 KATNAL1 ATP2C2 DNA2 DHX29 GNL1 EFL1 DNAH3 KIF23 DNAH10 CILP TOR2A CHD9 ATP9A HELQ TRAP1 ACIN1 DNAH11 | 2.91e-04 | 840 | 261 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KATNAL2 SPAST GBP7 EIF4A3 GARS1 RAB22A MCM6 KATNAL1 ATP2C2 DNA2 DHX29 GNL1 EFL1 DNAH3 KIF23 DNAH10 CILP TOR2A CHD9 ATP9A HELQ TRAP1 ACIN1 DNAH11 | 2.91e-04 | 840 | 261 | 24 | GO:0016818 |
| GeneOntologyMolecularFunction | phospholipid binding | BCAS3 SNX17 OBSCN SNX16 ATG2A MYCBPAP ITPR1 OSBPL5 PLTP BPIFC ANXA5 ATG2B PON1 PARD3B APOE EXOC8 MCTP1 WDFY3 | 3.38e-04 | 548 | 261 | 18 | GO:0005543 |
| GeneOntologyMolecularFunction | calcium ion binding | TTYH1 TBC1D9B CDH23 PCDH12 ITPR1 HMCN2 RPTN PCDH11X FAT4 CIB1 FAT3 ANXA5 PCDHB7 PCDHB4 PON1 PCDHB2 PCDHA4 TGM3 CDH22 MCTP1 CELSR2 VCAN | 3.60e-04 | 749 | 261 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | single-stranded 3'-5' DNA helicase activity | 5.06e-04 | 3 | 261 | 2 | GO:1990518 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KATNAL2 SPAST GBP7 EIF4A3 RAB22A MCM6 KATNAL1 ATP2C2 DNA2 DHX29 GNL1 EFL1 DNAH3 KIF23 DNAH10 TOR2A CHD9 ATP9A HELQ TRAP1 ACIN1 DNAH11 | 5.69e-04 | 775 | 261 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | lipid transfer activity | 8.83e-04 | 57 | 261 | 5 | GO:0120013 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 8.94e-04 | 15 | 261 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.25e-04 | 118 | 261 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 1.00e-03 | 4 | 261 | 2 | GO:0034617 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CYLD KATNAL2 SPAST BBS1 CEP76 KATNAL1 CUL7 SPICE1 KIAA0753 DNAJB13 STARD9 SYNE2 PKHD1 DYNLRB2 DYNLRB1 WASF1 PLTP DNAH3 KIF23 CIB1 DNAH10 ANXA5 PARD3B TACC2 GAS2L1 LLGL2 CELSR2 TTLL4 DOCK7 TRPV4 TMEM108 DNAH11 | 3.59e-06 | 1058 | 258 | 32 | GO:0007017 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDH23 PCDH12 HMCN2 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 4.37e-06 | 187 | 258 | 12 | GO:0007156 |
| Domain | Cadherin_CS | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 3.55e-07 | 109 | 260 | 11 | IPR020894 |
| Domain | CADHERIN_1 | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 5.12e-07 | 113 | 260 | 11 | PS00232 |
| Domain | Cadherin | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 5.12e-07 | 113 | 260 | 11 | PF00028 |
| Domain | - | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 5.60e-07 | 114 | 260 | 11 | 2.60.40.60 |
| Domain | CADHERIN_2 | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 5.60e-07 | 114 | 260 | 11 | PS50268 |
| Domain | CA | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 6.11e-07 | 115 | 260 | 11 | SM00112 |
| Domain | Cadherin-like | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 6.67e-07 | 116 | 260 | 11 | IPR015919 |
| Domain | Cadherin | CDH23 PCDH12 PCDH11X FAT4 FAT3 PCDHB7 PCDHB4 PCDHB2 PCDHA4 CDH22 CELSR2 | 7.92e-07 | 118 | 260 | 11 | IPR002126 |
| Domain | TMEM132D_N | 2.61e-05 | 5 | 260 | 3 | PF15705 | |
| Domain | TMEM132D_C | 2.61e-05 | 5 | 260 | 3 | PF15706 | |
| Domain | TMEM132 | 2.61e-05 | 5 | 260 | 3 | IPR026307 | |
| Domain | TMEM132_M | 2.61e-05 | 5 | 260 | 3 | IPR031437 | |
| Domain | TMEM132_C | 2.61e-05 | 5 | 260 | 3 | IPR031436 | |
| Domain | TMEM132_N | 2.61e-05 | 5 | 260 | 3 | IPR031435 | |
| Domain | TMEM132 | 2.61e-05 | 5 | 260 | 3 | PF16070 | |
| Domain | - | 5.42e-05 | 95 | 260 | 8 | 2.60.120.200 | |
| Domain | GPS | 1.01e-04 | 34 | 260 | 5 | SM00303 | |
| Domain | GPS | 1.16e-04 | 35 | 260 | 5 | PF01825 | |
| Domain | GPS | 1.33e-04 | 36 | 260 | 5 | PS50221 | |
| Domain | GPS | 1.52e-04 | 37 | 260 | 5 | IPR000203 | |
| Domain | LAM_G_DOMAIN | 1.73e-04 | 38 | 260 | 5 | PS50025 | |
| Domain | DYNLRB1/2 | 1.93e-04 | 2 | 260 | 2 | IPR016561 | |
| Domain | ATG2 | 1.93e-04 | 2 | 260 | 2 | IPR026849 | |
| Domain | ATG2_CAD | 1.93e-04 | 2 | 260 | 2 | PF13329 | |
| Domain | ATG2_CAD_motif | 1.93e-04 | 2 | 260 | 2 | IPR026885 | |
| Domain | Laminin_G_2 | 2.22e-04 | 40 | 260 | 5 | PF02210 | |
| Domain | ConA-like_dom | BSPRY ITGB4 TRIM11 PAPPA2 FAT4 FAT3 LAMA4 ADGRG6 CELSR2 CSPG4 WDFY3 | 2.60e-04 | 219 | 260 | 11 | IPR013320 |
| Domain | Cadherin_2 | 2.85e-04 | 65 | 260 | 6 | PF08266 | |
| Domain | Cadherin_N | 2.85e-04 | 65 | 260 | 6 | IPR013164 | |
| Domain | ARM-type_fold | CUL7 ITPR1 PI4KA IPO5 NCAPD3 UBR4 USP24 FRYL API5 PPP4R4 PPP2R5E PKP3 SERAC1 WDFY3 | 3.02e-04 | 339 | 260 | 14 | IPR016024 |
| Domain | LamG | 3.51e-04 | 44 | 260 | 5 | SM00282 | |
| Domain | Roadblock/LAMTOR2_dom | 5.74e-04 | 3 | 260 | 2 | IPR004942 | |
| Domain | Robl_LC7 | 5.74e-04 | 3 | 260 | 2 | SM00960 | |
| Domain | Robl_LC7 | 5.74e-04 | 3 | 260 | 2 | PF03259 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 6.39e-04 | 50 | 260 | 5 | PS00650 | |
| Domain | 7tm_2 | 6.39e-04 | 50 | 260 | 5 | PF00002 | |
| Domain | ATPase_dyneun-rel_AAA | 8.66e-04 | 14 | 260 | 3 | IPR011704 | |
| Domain | MT | 8.66e-04 | 14 | 260 | 3 | PF12777 | |
| Domain | AAA_8 | 8.66e-04 | 14 | 260 | 3 | PF12780 | |
| Domain | AAA_5 | 8.66e-04 | 14 | 260 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.66e-04 | 14 | 260 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 8.66e-04 | 14 | 260 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 8.66e-04 | 14 | 260 | 3 | IPR013602 | |
| Domain | DHC_N2 | 8.66e-04 | 14 | 260 | 3 | PF08393 | |
| Domain | DHC_fam | 1.07e-03 | 15 | 260 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 1.07e-03 | 15 | 260 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.07e-03 | 15 | 260 | 3 | IPR004273 | |
| Domain | - | 1.14e-03 | 222 | 260 | 10 | 1.25.10.10 | |
| Domain | Laminin_G | 1.26e-03 | 58 | 260 | 5 | IPR001791 | |
| Domain | GPCR_2_secretin-like | 1.47e-03 | 60 | 260 | 5 | IPR000832 | |
| Domain | GPCR_2-like | 1.47e-03 | 60 | 260 | 5 | IPR017981 | |
| Domain | ARM-like | PPP4R1L CUL7 IPO5 NCAPD3 FRYL API5 PPP4R4 PPP2R5E PKP3 SERAC1 WDFY3 | 1.47e-03 | 270 | 260 | 11 | IPR011989 |
| Domain | G_PROTEIN_RECEP_F2_4 | 1.59e-03 | 61 | 260 | 5 | PS50261 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D9B ACACA BCAS3 SPEG OBSCN PLXND1 ATG2A ITGB4 ITGB5 CABLES1 KMT2C BMP4 CHST15 PI4KA SURF6 MAD1L1 TMEM132A OSBPL5 USP7 NLRC5 PLEC VPS39 UBR4 ADGRL1 FRYL GAS2L1 LLGL2 POMGNT2 CELSR2 BTBD7 TTLL4 CSPG4 SENP2 WDFY3 UBE3C CEP170B | 2.47e-13 | 1105 | 265 | 36 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | IMPA2 ACACA BCAS3 SPTB OBSCN ADGRG1 TMPRSS5 KATNAL1 ITGB5 PHKB KMT2C PTPRB SUPT6H SPIN1 MAD1L1 OSBPL5 NLRC5 LRRC41 AMD1 NEDD4L CCDC85C ADGRL1 CHD9 PARD3B FRYL SHROOM2 PPP4R4 ADGRG6 GTF2I FAM13A PKP3 ANKRD17 ANKRD24 UBE3C ERMARD CEP170B | 1.04e-09 | 1489 | 265 | 36 | 28611215 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ACACA ERP44 EIF4A3 GARS1 MCM6 TM9SF2 PMPCA ANAPC1 SUPT6H STARD9 UBTF PI4KA USP7 ANP32E CKAP4 DHX29 IPO5 NCAPD3 KIF23 DNAH10 ANXA5 UBR4 BIRC3 API5 TGM3 TRAP1 GTF2I MDC1 DOCK7 ACIN1 UBE3C PEAK1 SEC63 | 1.56e-08 | 1425 | 265 | 33 | 30948266 |
| Pubmed | ACACA MCM6 CHKA INO80D ITGB5 TRAPPC13 KMT2C ANAPC1 UBTF USP7 PHLPP1 USP1 LRRC41 IPO5 EFL1 KIF23 ING3 KDM5A VPS39 UBR4 PPP4R4 TAF3 LLGL2 PPP2R5E GTF2I TRMT44 BTBD7 ANKRD17 EIF2AK1 SEC63 CLSPN | 3.64e-08 | 1327 | 265 | 31 | 32694731 | |
| Pubmed | ACACA MCM6 CUL7 ANAPC1 SUPT6H UBTF SURF6 SYNE2 USP7 PLEC IPO5 KIF23 UBR4 USP24 FRYL TGM3 GTF2I MDC1 DOCK7 ACIN1 ANKRD17 | 3.81e-08 | 653 | 265 | 21 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD SPAST ACACA BCAS3 SPICE1 KIAA0753 KSR1 STARD9 PI4KA SYNE2 MAD1L1 PLEC KIF23 NEDD4L KDM5A CCDC85C PARD3B FRYL PPP4R4 FAM13A DOCK7 ANKRD17 PEAK1 CEP170B | 5.85e-08 | 861 | 265 | 24 | 36931259 |
| Pubmed | CYLD ERP44 GBP7 OBSCN BCOR ITGB4 KIAA0753 ITPR1 PHKB KMT2C UBTF SPIN1 PI4KA PLEC DNA2 VPS39 FRYL TACC2 SHROOM2 PPP2R5E VCAN TTLL4 ACIN1 ANKRD17 PEAK1 SEC63 CDC27 | 8.28e-08 | 1084 | 265 | 27 | 11544199 | |
| Pubmed | 9.42e-08 | 30 | 265 | 6 | 19936222 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | ACACA CUL7 ANAPC1 SUPT6H LRRC41 NCAPD3 UBR4 GPX1 USP24 CCDC85C ANKRD17 UBE3C | 9.72e-08 | 212 | 265 | 12 | 33853758 |
| Pubmed | CYLD EARS2 CUL7 BCOR INO80D KSR1 HMCN2 ANAPC1 SURF6 USP7 CKAP4 DNA2 LRRC41 ING3 KDM5A FAT3 GPX1 CHD9 TTC7A TAF3 PPP2R5E MCTP1 ANKRD17 WDFY3 CLSPN CDC27 CEP170B | 1.48e-07 | 1116 | 265 | 27 | 31753913 | |
| Pubmed | SNX17 CUL7 BCOR SPICE1 KIAA0753 ITPR1 PHKB TRIM11 PTPRB PMPCA UBTF PI4KA SYNE2 USP7 PHLPP1 PDP2 CKAP4 USP1 WASF1 EFL1 CCDC85C PPP4R4 PPP2R5E LRP6 SENP2 PEAK1 | 1.60e-07 | 1049 | 265 | 26 | 27880917 | |
| Pubmed | NAT9 BCAS3 SPTB DAPK1 ITGA2 GPD1L PHKB SACS AJM1 PI4KA USP7 PLEC WASF1 DHX29 IPO5 NEDD4L OXR1 WDR7 MTERF1 ADGRL1 PLEKHA6 APOE ATP9A SHROOM2 GAS2L1 PPP2R5E VCAN DOCK7 PEAK1 CEP170B DNAH11 | 1.92e-07 | 1431 | 265 | 31 | 37142655 | |
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 1.99e-07 | 146 | 265 | 10 | 20686565 | |
| Pubmed | CYLD BCL9L SPAST ACACA BCAS3 ITPR1 AJM1 PI4KA USP7 CKAP4 PLEC WASF1 DHX29 NEDD4L UBR4 ATG2B USP24 BSDC1 ADGRL1 TACC2 SHROOM2 TRAP1 POMGNT2 CELSR2 DOCK7 PEAK1 CEP170B | 2.21e-07 | 1139 | 265 | 27 | 36417873 | |
| Pubmed | 2.63e-07 | 57 | 265 | 7 | 19263529 | ||
| Pubmed | 2.63e-07 | 57 | 265 | 7 | 19479237 | ||
| Pubmed | Association between dementia and vascular disease-associated polymorphisms in a Tunisian population. | 4.37e-07 | 3 | 265 | 3 | 28657841 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | ACACA ITGB4 PHKB ANAPC1 PI4KA PLEC IPO5 NCAPD3 FRYL DOCK7 ANKRD17 | 4.92e-07 | 202 | 265 | 11 | 33005030 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | EIF4A3 CEP76 CUL7 LSM3 SPICE1 PHKB SUPT6H CILP ANXA5 UBR4 PARD3B TRAP1 PPP2R5E GTF2I TRIM32 DOCK7 ANKRD17 CLSPN CDC27 | 5.66e-07 | 639 | 265 | 19 | 23443559 |
| Pubmed | 5.91e-07 | 64 | 265 | 7 | 19131662 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ERP44 ADGRG1 ITGA2 PLXND1 ITGB4 ITGB5 ITPR1 MIA2 TM9SF2 TMEM132A TXNDC16 DYNLRB1 TMCO3 CKAP4 GNS NCAPD3 SEMA3C FAT4 NEDD4L LAMA4 ATP9A POMGNT2 CELSR2 NETO2 CSPG4 LRP6 SEC63 | 6.18e-07 | 1201 | 265 | 27 | 35696571 |
| Pubmed | CYLD SPEG CHST15 STARD9 NEDD4L WDR7 ADGRL1 ATP9A PPP2R5E BTBD7 DOCK7 ACIN1 SENP2 UBE3C CEP170B | 6.58e-07 | 407 | 265 | 15 | 12693553 | |
| Pubmed | Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. | 7.31e-07 | 66 | 265 | 7 | 20679960 | |
| Pubmed | 9.34e-07 | 24 | 265 | 5 | 33705438 | ||
| Pubmed | 1.33e-06 | 72 | 265 | 7 | 36376293 | ||
| Pubmed | 1.55e-06 | 12 | 265 | 4 | 19008959 | ||
| Pubmed | BCL9L ACACA EIF4A3 LSM3 ITPR1 SUPT6H SPIN1 PI4KA SURF6 SYNE2 USP7 TMCO3 FAT4 ING3 WDR7 VPS39 ANXA5 MDC1 EIF2AK1 SEC63 | 1.65e-06 | 754 | 265 | 20 | 35906200 | |
| Pubmed | 1.74e-06 | 4 | 265 | 3 | 20406466 | ||
| Pubmed | Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. | 1.74e-06 | 4 | 265 | 3 | 11328206 | |
| Pubmed | Genetic factors associated with the absence of atherosclerosis in octogenarians. | 1.74e-06 | 4 | 265 | 3 | 12196500 | |
| Pubmed | 1.74e-06 | 4 | 265 | 3 | 18443916 | ||
| Pubmed | BCAS3 KMT2C STARD9 NPC1L1 OSBPL5 PCDH11X UAP1L1 DNAH3 UBR4 SHROOM2 DNAH11 | 2.00e-06 | 233 | 265 | 11 | 37704626 | |
| Pubmed | 2.10e-06 | 77 | 265 | 7 | 10835267 | ||
| Pubmed | 2.11e-06 | 28 | 265 | 5 | 32801337 | ||
| Pubmed | TTYH1 CYLD SPAST EIF4A3 SPTB DDIT4L MIA2 SACS SURF6 USP7 PLEC UAP1L1 IPO5 CIB1 OXR1 KDM5A SYNM VPS39 UBR4 CHD9 APOE SHROOM2 PPP2R5E TRIM32 ANKRD24 WDFY3 EIF2AK1 | 2.22e-06 | 1285 | 265 | 27 | 35914814 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 2.72e-06 | 80 | 265 | 7 | 10716726 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ERP44 EIF4A3 SACS SUPT6H SPIN1 SURF6 USP7 CKAP4 PLEC GNS NEDD4L WDR7 KDM5A ANXA5 CHD9 TAF3 TRIM32 VCAN MRPS15 DOCK7 ACIN1 SEC63 TNXB SPIN3 | 3.37e-06 | 1082 | 265 | 24 | 38697112 |
| Pubmed | SPAST EARS2 EIF4A3 SNX17 PLXND1 ATG2A BCOR KMT2C SUPT6H OSBPL5 DNA2 NCAPD3 VPS39 TTLL4 MDC1 ANKRD17 | 3.63e-06 | 529 | 265 | 16 | 14621295 | |
| Pubmed | EIF4A3 MCM6 TRIM11 ANAPC1 SUPT6H UBTF MAD1L1 USP7 ANP32E PLEC MED26 CDKN2AIPNL IPO5 EFL1 KIF23 ANXA5 UBR4 CHD9 API5 TAF3 GTF2I MDC1 ACIN1 | 3.78e-06 | 1014 | 265 | 23 | 32416067 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 3.78e-06 | 84 | 265 | 7 | 15203218 | |
| Pubmed | 4.21e-06 | 15 | 265 | 4 | 14746139 | ||
| Pubmed | 4.32e-06 | 5 | 265 | 3 | 21450592 | ||
| Pubmed | 4.32e-06 | 5 | 265 | 3 | 20160191 | ||
| Pubmed | 4.32e-06 | 5 | 265 | 3 | 17827148 | ||
| Pubmed | 4.32e-06 | 5 | 265 | 3 | 29088312 | ||
| Pubmed | BCL9L KATNAL2 RAB22A ADGRG1 BCOR INO80D LSM3 KMT2C ANAPC1 SUPT6H PI4KA SURF6 USP7 WDR89 DHX29 NCAPD3 SEMA3C ING3 KDM5A PCDHB7 API5 ATP9A PPP2R5E TRIM32 MDC1 ANKRD17 SEC63 CDC27 CEP170B | 4.47e-06 | 1497 | 265 | 29 | 31527615 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 4.93e-06 | 33 | 265 | 5 | 25713288 | |
| Pubmed | ACACA ITGA2 CABLES1 PI4KA CKAP4 GNS NEDD4L ADGRL1 PARD3B PLEKHA6 LLGL2 CELSR2 PEAK1 SEC63 | 5.10e-06 | 421 | 265 | 14 | 36976175 | |
| Pubmed | 5.11e-06 | 257 | 265 | 11 | 16335952 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 5.65e-06 | 211 | 265 | 10 | 24097068 | |
| Pubmed | Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. | 5.74e-06 | 34 | 265 | 5 | 19060911 | |
| Pubmed | ACACA BCOR KMT2C ANAPC1 USP7 KIF23 ATG2B USP24 CCDC85C APOE TAF3 GTF2I MDC1 DOCK7 ACIN1 PEAK1 | 5.79e-06 | 549 | 265 | 16 | 38280479 | |
| Pubmed | 5.93e-06 | 167 | 265 | 9 | 22159717 | ||
| Pubmed | 5.94e-06 | 59 | 265 | 6 | 20855565 | ||
| Pubmed | 6.56e-06 | 60 | 265 | 6 | 12082592 | ||
| Pubmed | 6.66e-06 | 35 | 265 | 5 | 18513389 | ||
| Pubmed | Lp(a) and risk of recurrent cardiac events in obese postinfarction patients. | 7.25e-06 | 17 | 265 | 4 | 18927546 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ACACA NAT9 SPEG OBSCN CEP76 NEB CABLES1 KMT2C PTPRB UBTF CROCC2 SURF6 USP7 CHD9 APOE | 7.52e-06 | 497 | 265 | 15 | 36774506 |
| Pubmed | IMPA2 SPTB OBSCN PCDH12 NEB ITGB5 SUPT6H SYNE2 PLEC USP1 IPO5 KDM5A LAMA4 PPP2R5E TRIM32 | 7.52e-06 | 497 | 265 | 15 | 23414517 | |
| Pubmed | Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta. | 8.60e-06 | 6 | 265 | 3 | 18813964 | |
| Pubmed | Effect of six candidate genes on early aging in a French population. | 8.60e-06 | 6 | 265 | 3 | 12889841 | |
| Pubmed | MCM6 ITGB4 CABLES1 MAD1L1 DHX29 KIF23 USP24 BOLA1 TACC2 PLEKHA6 SLX9 GTF2I FAM13A PKP3 ACIN1 | 8.67e-06 | 503 | 265 | 15 | 16964243 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ACACA BCOR SPICE1 ANAPC1 MAD1L1 USP7 PLEC DHX29 NCAPD3 KIF23 KDM5A USP24 TAF3 GTF2I FAM13A PKP3 MDC1 ACIN1 ANKRD17 | 9.08e-06 | 774 | 265 | 19 | 15302935 |
| Pubmed | 9.27e-06 | 18 | 265 | 4 | 23726366 | ||
| Pubmed | 9.57e-06 | 64 | 265 | 6 | 19729601 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | CYLD ERP44 BBS1 MCM6 ATG2A PMPCA SUPT6H RPTN USP7 PHLPP1 CKAP4 PLEC USP1 IPO5 NEDD4L EXOC8 TGM3 GTF2I DOCK7 ANKRD17 NUDCD1 CDC27 | 1.07e-05 | 1005 | 265 | 22 | 19615732 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | GARS1 BBS1 CDH23 MCM6 CEP76 KSR1 TRIM11 TM9SF2 DYNLRB2 DYNLRB1 MINDY4 PLEC WASF1 RAB3IL1 UNC119B ANXA5 ATG2B CCDC85C EXOC8 TRAP1 PPP2R5E GTF2I TRIM32 DOCK7 EIF2AK1 CDC27 | 1.09e-05 | 1321 | 265 | 26 | 27173435 |
| Pubmed | 1.40e-05 | 234 | 265 | 10 | 36243803 | ||
| Pubmed | A systematic meta-analysis of genetic association studies for diabetic retinopathy. | 1.45e-05 | 20 | 265 | 4 | 19587357 | |
| Pubmed | APC/CCdh1-dependent proteolysis of USP1 regulates the response to UV-mediated DNA damage. | 1.50e-05 | 7 | 265 | 3 | 21768287 | |
| Pubmed | Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. | IMPA2 EIF4A3 SPTB GARS1 ITGB4 PRR14 UBTF CROCC2 PI4KA USP7 C5 CKAP4 SEMA3C ANXA5 TRAP1 PKP3 DOCK7 ANKRD17 | 1.53e-05 | 732 | 265 | 18 | 34732716 |
| Pubmed | 1.83e-05 | 147 | 265 | 8 | 29576527 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 1.90e-05 | 72 | 265 | 6 | 10380929 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.22e-05 | 74 | 265 | 6 | 10817752 | |
| Pubmed | 2.23e-05 | 197 | 265 | 9 | 31620119 | ||
| Pubmed | ACACA ERP44 BCOR ANAPC1 PLEC KDM5A UBR4 ATG2B USP24 CCDC85C GTF2I DOCK7 ANKRD17 | 2.24e-05 | 418 | 265 | 13 | 34709266 | |
| Pubmed | 2.33e-05 | 152 | 265 | 8 | 19578796 | ||
| Pubmed | 2.44e-05 | 153 | 265 | 8 | 10718198 | ||
| Pubmed | ERP44 EIF4A3 MCM6 SURF6 USP7 CKAP4 PLEC IPO5 KIF23 ANXA5 GPX1 API5 TGM3 SLX9 PPP2R5E FAM13A TRIM32 DOCK7 PEAK1 SPIN3 | 2.83e-05 | 916 | 265 | 20 | 32203420 | |
| Pubmed | TBC1D9B ERP44 CUL7 KIAA0753 GPD1L SACS TMEM132A TXNDC16 SYNM PLEKHA6 PPP4R4 ANKRD24 PEAK1 EIF2AK1 | 2.96e-05 | 493 | 265 | 14 | 15368895 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | BCAS3 SNX17 MCM6 CUL7 TRAPPC13 ANAPC1 PI4KA MAD1L1 WASF1 LRRC41 NCAPD3 ING3 KDM5A MTERF1 UBR4 SLX9 POMGNT2 ANKRD17 CDC27 | 3.67e-05 | 857 | 265 | 19 | 25609649 |
| Pubmed | Intermediate phenotypes identify divergent pathways to Alzheimer's disease. | 3.67e-05 | 25 | 265 | 4 | 20574532 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ACACA MCM6 ITPR1 ANAPC1 SUPT6H UBTF DHX29 KIF23 VPS39 GTF2I MDC1 ANKRD17 CDC27 | 3.80e-05 | 440 | 265 | 13 | 34244565 |
| Pubmed | 5.05e-05 | 10 | 265 | 3 | 12966036 | ||
| Pubmed | Influence of polymorphisms in candidate genes on early vascular alterations in obese children. | 5.05e-05 | 10 | 265 | 3 | 20142115 | |
| Pubmed | 5.05e-05 | 10 | 265 | 3 | 16928730 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 5.17e-05 | 170 | 265 | 8 | 23314748 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CYLD BCAS3 SNX17 SNX16 ATG2A SPICE1 KSR1 WDR89 OSCP1 NEDD4L CCDC85C PLEKHA6 SLX9 BTBD7 PKP3 TTLL4 GSTCD DOCK7 ZC3H12C CLSPN CDC27 | 5.35e-05 | 1038 | 265 | 21 | 26673895 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ACACA ERP44 EIF4A3 GARS1 MCM6 MAD1L1 USP7 ANP32E DYNLRB1 PLEC GNL1 GNS IPO5 EFL1 OXR1 UBR4 GPX1 USP24 FRYL SCLY API5 TRAP1 PPP2R5E GTF2I UBE3C NUDCD1 | 5.55e-05 | 1455 | 265 | 26 | 22863883 |
| Pubmed | 5.57e-05 | 87 | 265 | 6 | 12465718 | ||
| Pubmed | CYLD DAPK1 BCOR TMEM132B SPICE1 ANAPC1 PI4KA SYNE2 MAD1L1 WASF1 KIF23 NEDD4L WDR7 KDM5A UBR4 CELSR2 DOCK7 ANKRD17 WDFY3 CEP170B | 5.66e-05 | 963 | 265 | 20 | 28671696 | |
| Pubmed | 5.77e-05 | 54 | 265 | 5 | 20536507 | ||
| Pubmed | Common variants at 30 loci contribute to polygenic dyslipidemia. | 5.77e-05 | 54 | 265 | 5 | 19060906 | |
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 25651711 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 17900358 | ||
| Pubmed | Association between genetic polymorphisms of ACE & eNOS and diabetic nephropathy. | 5.78e-05 | 2 | 265 | 2 | 25227524 | |
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 12459519 | ||
| Pubmed | PLTP secreted by HepG2 cells resembles the high-activity PLTP form in human plasma. | 5.78e-05 | 2 | 265 | 2 | 12810820 | |
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 28800131 | ||
| Pubmed | 5.78e-05 | 2 | 265 | 2 | 26337529 | ||
| Interaction | TOP3B interactions | TBC1D9B ACACA BCAS3 SPEG SPTB OBSCN PLXND1 ATG2A ITGB4 ITGB5 CABLES1 KMT2C BMP4 ANOS1 CHST15 PI4KA SURF6 MAD1L1 TMEM132A OSBPL5 USP7 NLRC5 PLEC DNA2 IPO5 KIF23 VPS39 UBR4 ADGRL1 FRYL GAS2L1 LLGL2 GTF2I POMGNT2 CELSR2 BTBD7 TTLL4 CSPG4 MDC1 ACIN1 ANKRD17 SENP2 WDFY3 UBE3C CEP170B | 6.92e-08 | 1470 | 263 | 45 | int:TOP3B |
| Interaction | LGALS1 interactions | CYLD ITGA2 PLXND1 ACE ITGB5 PTPRB FAT4 KIF23 FAT3 LAMA4 MUC16 LINGO2 TRAP1 GTF2I CELSR2 VCAN CSPG4 | 1.89e-06 | 332 | 263 | 17 | int:LGALS1 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 3.03e-05 | 7 | 175 | 3 | 917 | |
| GeneFamily | Dyneins, axonemal | 5.49e-04 | 17 | 175 | 3 | 536 | |
| GeneFamily | Cadherin related | 5.49e-04 | 17 | 175 | 3 | 24 | |
| GeneFamily | Tudor domain containing|Spindlin family | 9.14e-04 | 5 | 175 | 2 | 1089 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | TBC1D9B IMPA2 ATG2A ITGB5 ITPR1 PMPCA PLEC GNS PLTP SYNM GTF2I CELSR2 VCAN | 5.08e-06 | 276 | 264 | 13 | M3063 |
| Coexpression | GSE14350_IL2RB_KO_VS_WT_TEFF_DN | GBP7 BSPRY PLXND1 NEB TRAPPC13 PCDH11X TOR2A TACC2 SHROOM2 HELQ VCAN | 6.38e-06 | 200 | 264 | 11 | M3424 |
| Coexpression | LEE_BMP2_TARGETS_UP | GBP7 BSPRY DDIT4L DAPK1 CUL7 ITGB4 RTN2 ITGB5 ANOS1 PTPRB LIPG STARD9 MINDY4 UAP1L1 PLTP OPLAH ADAMTSL1 CILP PARD3B APOE ADGRG6 MTURN TNXB | 7.97e-06 | 805 | 264 | 23 | MM1067 |
| Coexpression | LEE_BMP2_TARGETS_UP | GBP7 BSPRY DDIT4L DAPK1 CUL7 ITGB4 RTN2 ITGB5 PTPRB LIPG STARD9 MINDY4 UAP1L1 PLTP OPLAH ADAMTSL1 CILP PARD3B APOE ADGRG6 MTURN TNXB | 1.54e-05 | 780 | 264 | 22 | M2324 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | SPAST ADGRG1 DAPK1 SNX16 BCOR TRAPPC13 TM9SF2 SACS SYNE2 MAD1L1 ANP32E GNS PLTP OXR1 ADGRL1 TACC2 ATP9A NETO2 CSPG4 ACIN1 SEC63 CDC27 | 1.87e-05 | 790 | 264 | 22 | M12490 |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_2 | 2.77e-05 | 154 | 264 | 9 | M39034 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | DDIT4L ACE ITGB5 ITPR1 BMP4 CILP LAMA4 PLEKHA6 VCAN CSPG4 TNXB | 2.18e-08 | 191 | 265 | 11 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | DAPK1 ITGB4 INO80D PTPRB CHST15 PCDH11X ADAMTSL1 SHROOM2 ADGRG6 VCAN TMEM108 | 2.30e-08 | 192 | 265 | 11 | c0c34785a7bdf461722029b322e9184e3d9b3c26 |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | ZNF366 PLXND1 ITGB4 INO80D PTPRB PCDH11X NOS3 ADAMTSL1 SHROOM2 ADGRG6 TMEM108 | 2.56e-08 | 194 | 265 | 11 | b6cc849fa08599bff9839ef382d190cc964e273e |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TSPAN18 ZNF366 PLXND1 PTPRB STARD9 OSBPL5 PHLPP1 CMKLR1 NOS3 PEAK1 TNXB | 3.00e-08 | 197 | 265 | 11 | 412cb5f37df57121ddd1492021445479c7cbccbf |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-07 | 186 | 265 | 10 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | ZNF366 PLXND1 BCOR ITGB4 INO80D PTPRB PCDH11X NOS3 ADAMTSL1 SHROOM2 | 1.92e-07 | 187 | 265 | 10 | 7876dcb4800c2e54874df3d933efb79307a64a97 |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.33e-07 | 191 | 265 | 10 | d162917816dd2e4767c97447c1cddae9397713ab | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 146 | 265 | 9 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CDH23 PLXND1 PCDH12 ITGB4 PTPRB OSBPL5 CMKLR1 ADAMTSL1 ADGRG6 TNXB | 2.57e-07 | 193 | 265 | 10 | daefbfd3a3dd1351fbe94b9abfd807db44d56c24 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TSPAN18 ZNF366 PLXND1 PTPRB STARD9 PHLPP1 CMKLR1 NOS3 PEAK1 TNXB | 3.11e-07 | 197 | 265 | 10 | cd509e49bbdbf991cc5913960ff3ef275ad40628 |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.41e-07 | 199 | 265 | 10 | 6c0354f57883330c685a8d9d5d3014ace7eca584 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TSPAN18 PCDH12 ACE KMT2C PTPRB CHST15 SYNE2 FAT4 LAMA4 MCTP1 | 3.57e-07 | 200 | 265 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.57e-07 | 200 | 265 | 10 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | KATNAL2 DNAJB13 CROCC2 ATP2C2 OSCP1 DNAH3 DNAH10 TGM3 DNAH11 | 3.75e-07 | 154 | 265 | 9 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | KATNAL2 DNAJB13 CROCC2 ATP2C2 OSCP1 DNAH3 DNAH10 TGM3 DNAH11 | 3.75e-07 | 154 | 265 | 9 | 58072ce422d09f2de602580325eaac6c4ec6c136 |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.95e-07 | 173 | 265 | 9 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.04e-06 | 174 | 265 | 9 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-erythroid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | SPTB ITGA2 CABLES1 GOLGA7B RAB3IL1 APOE ATP9A ANKRD24 CEP170B | 1.20e-06 | 177 | 265 | 9 | b647667da62a91dbe3890820142626e26aa779d2 |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-06 | 178 | 265 | 9 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 137 | 265 | 8 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.74e-06 | 185 | 265 | 9 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.90e-06 | 187 | 265 | 9 | 59e31c51183ed4c9a3d0792c8005ea3a12b28dfa | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 187 | 265 | 9 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | Endothelial-Endothelial-E|Endothelial / shred on cell class and cell subclass (v4) | 1.98e-06 | 188 | 265 | 9 | 2777eb7689b271c199021fe7d9db88ccebff14de | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-06 | 189 | 265 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.07e-06 | 189 | 265 | 9 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.16e-06 | 190 | 265 | 9 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | DAPK1 PTPRB SYNE2 PCDH11X ADAMTSL1 OXR1 SHROOM2 ADGRG6 TMEM108 | 2.46e-06 | 193 | 265 | 9 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.57e-06 | 194 | 265 | 9 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.16e-06 | 199 | 265 | 9 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.16e-06 | 199 | 265 | 9 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.16e-06 | 199 | 265 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.29e-06 | 200 | 265 | 9 | 9103e6f72a04f66f2b7069b0d71a719e9b10026b | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.29e-06 | 200 | 265 | 9 | e5e97767beb4413e87c9817a60a5f1ee5209198a | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.29e-06 | 200 | 265 | 9 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 3.29e-06 | 200 | 265 | 9 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.29e-06 | 200 | 265 | 9 | 48fd48990a6833066be314dc5b66b90893f7ea8f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.29e-06 | 200 | 265 | 9 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 3.50e-06 | 151 | 265 | 8 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 3.68e-06 | 152 | 265 | 8 | 4f690aed23338687bdefc47e8a2f3d1fdb2b6447 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-06 | 154 | 265 | 8 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-06 | 154 | 265 | 8 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-06 | 155 | 265 | 8 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-06 | 155 | 265 | 8 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.13e-06 | 159 | 265 | 8 | a710551512aa0b7a281a81bea651a43c9f3b3539 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.16e-06 | 163 | 265 | 8 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-06 | 164 | 265 | 8 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.04e-06 | 166 | 265 | 8 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.04e-06 | 166 | 265 | 8 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 7.36e-06 | 167 | 265 | 8 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.53e-06 | 173 | 265 | 8 | b9dee61973559e8c2fef3f2dafd43475b386befb | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 175 | 265 | 8 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 175 | 265 | 8 | 90302e8a44858ef3b2a165b88284d4788d591a99 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 175 | 265 | 8 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 177 | 265 | 8 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-05 | 178 | 265 | 8 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-05 | 179 | 265 | 8 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 180 | 265 | 8 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 180 | 265 | 8 | cea62fc006d68c3815c88bf17ec2617d7e41c3d2 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.27e-05 | 180 | 265 | 8 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-monocytoid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-05 | 180 | 265 | 8 | ba4c1fb55e8f1095bea6968417fefcf5f700926b | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 180 | 265 | 8 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 180 | 265 | 8 | 41e8155cc7b3dac9d496e4077845ca6af1591a5c | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 181 | 265 | 8 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.32e-05 | 181 | 265 | 8 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-05 | 181 | 265 | 8 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 182 | 265 | 8 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.43e-05 | 183 | 265 | 8 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 183 | 265 | 8 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 184 | 265 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 184 | 265 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c11-MKI67-FOS|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-05 | 184 | 265 | 8 | 7f8488dbb1ee41372cdbcd34a2e14b377218bf0f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 184 | 265 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.49e-05 | 184 | 265 | 8 | 8ed22b1af04a711203293e7a8b3df6fb9222fad5 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 186 | 265 | 8 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 186 | 265 | 8 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|bone_marrow / Manually curated celltypes from each tissue | 1.61e-05 | 186 | 265 | 8 | e82d5e7a976b9cfa2b4640c7a7cd1cfea19c4806 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 187 | 265 | 8 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 187 | 265 | 8 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-05 | 187 | 265 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-05 | 187 | 265 | 8 | 3699d5e71d779da922920aa3160895db187bf81b | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-05 | 187 | 265 | 8 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.68e-05 | 187 | 265 | 8 | 033ba52c0c2f9978784947098fa697368ae44834 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-05 | 187 | 265 | 8 | 7170694a1b86fe8d84d96c880ffe57af09bdc026 | |
| ToppCell | P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.74e-05 | 188 | 265 | 8 | 5bc1537e079c7435196c163bff5f639ea392a33a | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.81e-05 | 189 | 265 | 8 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.81e-05 | 189 | 265 | 8 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.81e-05 | 189 | 265 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 189 | 265 | 8 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.95e-05 | 191 | 265 | 8 | 44c596984c6196f6014e0e405dbe5560841e54ff | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-05 | 191 | 265 | 8 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 191 | 265 | 8 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | E16.5-samps-Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.95e-05 | 191 | 265 | 8 | e7521d4d24f016d4e531cd492a7a69604f0c9e6f | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.95e-05 | 191 | 265 | 8 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-05 | 191 | 265 | 8 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 192 | 265 | 8 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 192 | 265 | 8 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 192 | 265 | 8 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-05 | 192 | 265 | 8 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 192 | 265 | 8 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | GARS1 PMPCA LIPG SYNE2 NPC1L1 NLRC5 USP1 PLTP DNAH10 USP24 APOE CELSR2 LPA DOCK7 | 2.45e-07 | 291 | 252 | 14 | EFO_0008317, EFO_0020946 |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | GARS1 PMPCA LIPG SYNE2 NPC1L1 NLRC5 USP1 DNAH10 USP24 APOE CELSR2 LPA DOCK7 | 5.10e-07 | 264 | 252 | 13 | EFO_0008317, EFO_0020944 |
| Disease | Cardiovascular Diseases | 5.74e-07 | 36 | 252 | 6 | C0007222 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 5.74e-07 | 36 | 252 | 6 | EFO_0022257 | |
| Disease | total lipids in very large HDL measurement | 1.55e-06 | 66 | 252 | 7 | EFO_0022312 | |
| Disease | Coronary heart disease | 1.63e-06 | 24 | 252 | 5 | C0010068 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.71e-06 | 43 | 252 | 6 | EFO_0022254 | |
| Disease | myocardial infarction (is_implicated_in) | 2.22e-06 | 99 | 252 | 8 | DOID:5844 (is_implicated_in) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 5.24e-06 | 111 | 252 | 8 | EFO_0004530, EFO_0008595 | |
| Disease | cholesterol to total lipids in very large HDL percentage | 6.19e-06 | 31 | 252 | 5 | EFO_0022243 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 6.19e-06 | 31 | 252 | 5 | EFO_0022249 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 7.17e-06 | 153 | 252 | 9 | EFO_0004611, EFO_0020946 | |
| Disease | cholesterol to total lipids in large HDL percentage | 7.47e-06 | 55 | 252 | 6 | EFO_0022234 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | PMPCA LIPG NLRC5 PLTP DNAH10 PON1 APOE CELSR2 FAM13A LPA DOCK7 | 8.64e-06 | 243 | 252 | 11 | EFO_0004612, EFO_0020944 |
| Disease | cholesteryl esters to total lipids in large HDL percentage | 1.13e-05 | 59 | 252 | 6 | EFO_0022248 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 1.13e-05 | 17 | 252 | 4 | EFO_0022232 | |
| Disease | free cholesterol in small HDL measurement | 1.15e-05 | 35 | 252 | 5 | EFO_0022270 | |
| Disease | iron deficiency anemia (is_implicated_in) | 1.21e-05 | 6 | 252 | 3 | DOID:11758 (is_implicated_in) | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | MCM6 LIPG NLRC5 USP1 PLTP PON1 APOE CDH22 CELSR2 LPA DOCK7 DNAH11 | 1.30e-05 | 303 | 252 | 12 | EFO_0004612, EFO_0020945 |
| Disease | phospholipids in HDL measurement | 1.37e-05 | 61 | 252 | 6 | EFO_0022293 | |
| Disease | cholesteryl ester measurement | SNX17 LIPG NLRC5 RAB3IL1 PLTP DNAH10 PON1 APOE CELSR2 LPA DOCK7 | 1.46e-05 | 257 | 252 | 11 | EFO_0010351 |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | MCM6 PMPCA LIPG NLRC5 PLTP PON1 APOE CELSR2 FAM13A LPA DOCK7 DNAH11 | 1.48e-05 | 307 | 252 | 12 | EFO_0004612, EFO_0020946 |
| Disease | free cholesterol in very large HDL measurement | 1.51e-05 | 62 | 252 | 6 | EFO_0022273 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 1.52e-05 | 37 | 252 | 5 | EFO_0022281 | |
| Disease | very low density lipoprotein cholesterol measurement | SNX17 LIPG NPC1L1 PLTP DNAH10 APOE CELSR2 LPA DHRS9 DOCK7 DNAH11 | 1.63e-05 | 260 | 252 | 11 | EFO_0008317 |
| Disease | high density lipoprotein particle size measurement | 1.67e-05 | 170 | 252 | 9 | EFO_0008592 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | LIPG NLRC5 USP1 PLTP DNAH10 PON1 APOE CDH22 CELSR2 FAM13A LPA DOCK7 | 1.91e-05 | 315 | 252 | 12 | EFO_0004612, EFO_0008591 |
| Disease | triglycerides to total lipids in large VLDL percentage | 1.98e-05 | 39 | 252 | 5 | EFO_0022332 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 2.14e-05 | 220 | 252 | 10 | EFO_0004529, EFO_0008317 | |
| Disease | phospholipids in very large HDL measurement | 2.16e-05 | 66 | 252 | 6 | EFO_0022298 | |
| Disease | cholesterol in very small VLDL measurement | 2.25e-05 | 40 | 252 | 5 | EFO_0022231 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.32e-05 | 222 | 252 | 10 | EFO_0008317, EFO_0020943 | |
| Disease | Adenoid Cystic Carcinoma | 2.48e-05 | 100 | 252 | 7 | C0010606 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 2.60e-05 | 225 | 252 | 10 | EFO_0008317, EFO_0020947 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 2.60e-05 | 225 | 252 | 10 | EFO_0008317, EFO_0010351 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 2.77e-05 | 21 | 252 | 4 | EFO_0022246 | |
| Disease | cholesterol in very large HDL measurement | 2.79e-05 | 69 | 252 | 6 | EFO_0022229 | |
| Disease | free cholesterol to total lipids in IDL percentage | 3.22e-05 | 43 | 252 | 5 | EFO_0022278 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.22e-05 | 43 | 252 | 5 | EFO_0022290 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.51e-05 | 144 | 252 | 8 | EFO_0004611, EFO_0020943 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.86e-05 | 189 | 252 | 9 | EFO_0009932 | |
| Disease | total lipids in very small VLDL measurement | 4.04e-05 | 45 | 252 | 5 | EFO_0022156 | |
| Disease | remnant cholesterol measurement | 4.08e-05 | 108 | 252 | 7 | EFO_0010815 | |
| Disease | total lipids in lipoprotein particles measurement | 5.54e-05 | 48 | 252 | 5 | EFO_0022309 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 5.98e-05 | 200 | 252 | 9 | EFO_0004611, EFO_0020945 | |
| Disease | free cholesterol in large HDL measurement | 6.03e-05 | 79 | 252 | 6 | EFO_0022157 | |
| Disease | antihyperlipidemic drug use measurement | 6.10e-05 | 115 | 252 | 7 | EFO_0803367 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 6.13e-05 | 49 | 252 | 5 | EFO_0022256 | |
| Disease | diabetic retinopathy (is_implicated_in) | 6.76e-05 | 50 | 252 | 5 | DOID:8947 (is_implicated_in) | |
| Disease | Congenital bilateral perisylvian syndrome | 7.27e-05 | 2 | 252 | 2 | cv:C1845668 | |
| Disease | Gastrointestinal defect and immunodeficiency syndrome | 7.27e-05 | 2 | 252 | 2 | cv:C5234880 | |
| Disease | Epidermolysis Bullosa Simplex With Pyloric Atresia | 7.27e-05 | 2 | 252 | 2 | C2677349 | |
| Disease | Junctional epidermolysis bullosa with pyloric atresia | 7.27e-05 | 2 | 252 | 2 | cv:C5676875 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 5B, WITH PYLORIC ATRESIA | 7.27e-05 | 2 | 252 | 2 | 226730 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 7.99e-05 | 120 | 252 | 7 | EFO_0004611, EFO_0004639 | |
| Disease | phospholipids in medium VLDL measurement | 8.18e-05 | 52 | 252 | 5 | EFO_0022154 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | ZNF366 LIPG NLRC5 PLTP DNAH10 PON1 APOE CELSR2 FAM13A LPA DOCK7 | 8.50e-05 | 312 | 252 | 11 | EFO_0004612, EFO_0010351 |
| Disease | total phospholipids in lipoprotein particles measurement | 8.97e-05 | 53 | 252 | 5 | EFO_0022315 | |
| Disease | cholesterol in small VLDL measurement | 8.97e-05 | 53 | 252 | 5 | EFO_0022228 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | LIPG NLRC5 PLTP DNAH10 PON1 APOE CDH22 CELSR2 FAM13A LPA DOCK7 | 9.25e-05 | 315 | 252 | 11 | EFO_0004574, EFO_0004612 |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 9.57e-05 | 166 | 252 | 8 | EFO_0004530, EFO_0004611 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 9.71e-05 | 86 | 252 | 6 | EFO_0008595, EFO_0020945 | |
| Disease | triglycerides in medium HDL measurement | 9.81e-05 | 54 | 252 | 5 | EFO_0022321 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.04e-04 | 215 | 252 | 9 | EFO_0008317, EFO_0008591 | |
| Disease | cerebral infarction (is_implicated_in) | 1.04e-04 | 29 | 252 | 4 | DOID:3526 (is_implicated_in) | |
| Disease | triglycerides in medium VLDL measurement | 1.07e-04 | 55 | 252 | 5 | EFO_0022155 | |
| Disease | triglycerides in very large HDL measurement | 1.07e-04 | 55 | 252 | 5 | EFO_0022324 | |
| Disease | phospholipids in medium HDL measurement | 1.07e-04 | 55 | 252 | 5 | EFO_0022295 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | LIPG NLRC5 PLTP DNAH10 PON1 APOE CDH22 CELSR2 FAM13A LPA DOCK7 | 1.09e-04 | 321 | 252 | 11 | EFO_0004612, EFO_0004639 |
| Disease | triglycerides in LDL measurement | 1.17e-04 | 56 | 252 | 5 | EFO_0022320 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 1.17e-04 | 56 | 252 | 5 | EFO_0022333 | |
| Disease | protein CEI measurement | 1.28e-04 | 12 | 252 | 3 | EFO_0801936 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.33e-04 | 91 | 252 | 6 | EFO_0004611, EFO_0005271 | |
| Disease | fatty liver disease (implicated_via_orthology) | 1.36e-04 | 31 | 252 | 4 | DOID:9452 (implicated_via_orthology) | |
| Disease | total lipids in medium HDL measurement | 1.38e-04 | 58 | 252 | 5 | EFO_0022310 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | LIPG NLRC5 PLTP DNAH10 PON1 APOE CDH22 CELSR2 FAM13A LPA DOCK7 | 1.39e-04 | 330 | 252 | 11 | EFO_0004529, EFO_0004612 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.42e-04 | 224 | 252 | 9 | EFO_0004530, EFO_0008317 | |
| Disease | total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.42e-04 | 224 | 252 | 9 | EFO_0004574, EFO_0008317 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.43e-04 | 276 | 252 | 10 | EFO_0004612, EFO_0020943 | |
| Disease | Neurodevelopmental Disorders | 1.50e-04 | 93 | 252 | 6 | C1535926 | |
| Disease | Malignant neoplasm of breast | TBC1D9B SPAST ZNF366 OBSCN PHKB BMP4 MIA2 SYNE2 SCNN1B NLRC5 NOS3 VPS39 UBR4 GPX1 TACC2 SHROOM2 HELQ LLGL2 FCRL5 CLSPN CDC27 PRODH | 1.50e-04 | 1074 | 252 | 22 | C0006142 |
| Disease | phospholipids:total lipids ratio | 1.57e-04 | 227 | 252 | 9 | EFO_0020946 | |
| Disease | triglycerides to total lipids in large HDL percentage | 1.63e-04 | 60 | 252 | 5 | EFO_0022330 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.63e-04 | 60 | 252 | 5 | EFO_0022237 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.67e-04 | 229 | 252 | 9 | EFO_0004639, EFO_0008317 | |
| Disease | free cholesterol in HDL measurement | 1.76e-04 | 61 | 252 | 5 | EFO_0022264 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 1.83e-04 | 137 | 252 | 7 | EFO_0004611, EFO_0008591 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.97e-04 | 34 | 252 | 4 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | apolipoprotein B measurement | SNX17 BBS1 PMPCA SYNE2 NPC1L1 PLEC USP1 PLTP DNAH10 USP24 APOE PPP4R4 CELSR2 LPA DOCK7 DNAH11 | 2.06e-04 | 663 | 252 | 16 | EFO_0004615 |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.09e-04 | 14 | 252 | 3 | EFO_0004611, EFO_0008589 | |
| Disease | anemia (is_implicated_in) | 2.09e-04 | 14 | 252 | 3 | DOID:2355 (is_implicated_in) | |
| Disease | Sphingomyelin (d18:1/21:0, d17:1/22:0, d16:1/23:0) measurement | 2.17e-04 | 3 | 252 | 2 | EFO_0022111 | |
| Disease | angiopoietin-related protein 3 measurement | 2.17e-04 | 3 | 252 | 2 | EFO_0020148 | |
| Disease | Coronary Artery Vasospasm | 2.17e-04 | 3 | 252 | 2 | C0010073 | |
| Disease | Truncus Arteriosus, Persistent | 2.17e-04 | 3 | 252 | 2 | C0041207 | |
| Disease | Bilateral Periventricular Nodular Heterotopia | 2.17e-04 | 3 | 252 | 2 | C4551969 | |
| Disease | Epidermolysis bullosa with pyloric atresia | 2.17e-04 | 3 | 252 | 2 | C1856934 | |
| Disease | N-palmitoyl-sphinganine (d18:0/16:0) measurement | 2.17e-04 | 3 | 252 | 2 | EFO_0800428 | |
| Disease | response to darapladib, lipoprotein-associated phospholipase A(2) change measurement | 2.17e-04 | 3 | 252 | 2 | EFO_0008395, EFO_0008432 | |
| Disease | Periventricular Heterotopia, X-Linked | 2.17e-04 | 3 | 252 | 2 | C1848213 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VRTELTTLEEVLEPR | 151 | Q9H313 | |
| DFQSSLERPELELSR | 186 | Q9UKV3 | |
| VLQLLELFDSEDPRE | 181 | Q16537 | |
| TLERDVLQPLSRLSE | 126 | Q6ZT62 | |
| RLVPDSDVEELLQIL | 1071 | P53355 | |
| LEEQLTPVAEETRAR | 96 | P02649 | |
| VNEIDRRSTILPTAE | 2051 | P13611 | |
| QEELRLQTPAETLLS | 91 | Q6UVK1 | |
| LLRSEESVSRLPEEI | 356 | Q07065 | |
| TLREEAPTDLRVFEL | 356 | Q9NW68 | |
| TPSLEQDLERLFQEL | 831 | P12821 | |
| LRPAERDSDVVNVSL | 41 | P07510 | |
| ENLSPEDSVLVRRAQ | 731 | Q86SQ4 | |
| VETVDNLLRPEALES | 621 | O94910 | |
| LEERAERETESQVNP | 186 | Q7Z2Z2 | |
| RRFQTIDIEPDIEAL | 181 | P07203 | |
| IDRESLPSDVINLVV | 96 | Q6V0I7 | |
| PEITITDNDLRATER | 531 | C9J069 | |
| PLEVRLLESAELTTF | 596 | Q8IYT2 | |
| STLELRLQPEESFIL | 2141 | Q96DT5 | |
| RDPTLTDELLNILTE | 1051 | Q13085 | |
| TEDVSDLPVEEQLRR | 536 | Q13489 | |
| QRIAQDVLRLSSTEP | 86 | Q96D03 | |
| PRVADILTQLLQTDD | 96 | Q9BZZ5 | |
| LRNRSPEEVTELVLD | 11 | Q9BTT0 | |
| NALTAVIREDPSILE | 41 | Q3KP44 | |
| ILAETIREELAPDQQ | 31 | Q8TAP6 | |
| PVTVQFRLLETEERT | 2301 | Q9HCU4 | |
| ERFRLLETSPSTEEI | 771 | Q96K78 | |
| EEALSPEVLELRNES | 41 | Q9Y3E2 | |
| TEIIASRTPEELRAI | 111 | P08758 | |
| ELREASEALRQSVVP | 901 | Q8TF21 | |
| TVDPETQARLEALLE | 166 | O75179 | |
| ISAREELVQRIPEAS | 1376 | Q9Y4F5 | |
| LSLESANVEDLEPVR | 536 | Q7Z478 | |
| TVRDIDPQNDLTFLR | 56 | Q9NP97 | |
| DTDDLDLNSLRIQPV | 781 | Q9H6U6 | |
| SIPENEVISSAELRL | 146 | P12644 | |
| EDPTLRNRFSEILET | 756 | Q6W2J9 | |
| TILIDDINDSRPEFL | 2161 | Q9H251 | |
| VPLLEDTSRLEDINL | 31 | P51861 | |
| PADIRLTEVTDLLVD | 201 | O75185 | |
| AEQLRLELSEPQFRS | 666 | Q2TAZ0 | |
| VSVDESRPELIFRLA | 496 | Q96BY7 | |
| AEEDLETLLQSRVLP | 116 | Q8N0X4 | |
| LVRAAVEDNTLTIEP | 266 | Q8TBN0 | |
| NELFIEISRRIPSTD | 156 | Q9UL26 | |
| QQTEDDLTVTIRLPE | 281 | Q96RS6 | |
| ELEISESASLRTRIP | 141 | Q9NPG4 | |
| ALDREEQPEIRLTLT | 201 | Q9Y5E7 | |
| PQIIRENSISLSEIE | 1431 | Q9H1A4 | |
| EERNVPLATDLIRIS | 111 | P51959 | |
| AQTTDERVQLTDIRP | 241 | P23352 | |
| RTEPNSFLTIELRDV | 4006 | Q8WXI7 | |
| VVPDSTQNLEDREVL | 166 | Q8TEW8 | |
| QTREPREVIFEDVLL | 326 | Q9NUD7 | |
| TVRDIDPQNDLTFLR | 56 | Q8TF09 | |
| EELIRPERNTLVVSF | 51 | Q14566 | |
| PRSLEVILRAEAVES | 221 | Q14566 | |
| ISLDEERTVVLQTDP | 96 | P23467 | |
| LDTAPTLDLNRVLDE | 246 | Q6A162 | |
| QLQLLEEPETVVSRE | 666 | Q8NEZ4 | |
| DLTQLELNRPTDVTL | 346 | Q6DN14 | |
| LSIRTPEDLSRFVVE | 326 | Q9Y6D9 | |
| PEDLSRFVVELQQRE | 331 | Q9Y6D9 | |
| QDLPISRENLTDLVV | 636 | Q14676 | |
| DRTISSDAVLQRLPE | 166 | Q6P1M3 | |
| EPTTQITEEVRDQLL | 1911 | Q14643 | |
| NTPFELIATEETERR | 16 | Q8N3F0 | |
| ELLQTPNFRITVVDD | 181 | Q8N335 | |
| PELDSRIERQLFEET | 41 | Q2TAP0 | |
| TLTADPTVFQRELRE | 91 | Q8NDA2 | |
| SSDREAVLITLNRPI | 3256 | Q2LD37 | |
| ETQALILAPTRELAV | 106 | P38919 | |
| ASEELSQVPDEELLR | 11 | A6NKD9 | |
| VPTQLEDIRALLAAT | 1376 | Q8N6G6 | |
| TEILERRSLELDTPS | 116 | Q9NXR8 | |
| FLEQELETITIPDLR | 41 | P55058 | |
| RFENTPEIAIRSLDT | 231 | Q9Y4D7 | |
| ILRETPDNILEVQES | 66 | Q96RD9 | |
| EVVQEIPRDLTLDAL | 121 | Q8IVT5 | |
| DLPRIQLDIVTTADF | 496 | Q8IYT4 | |
| ETPLQLLRFSELISD | 81 | A0A1W2PR82 | |
| LRDQSRLAPEIITAT | 1571 | Q9H792 | |
| RSPNTDREVLQELIF | 716 | Q14999 | |
| LQIRDETPTLEASLD | 2541 | O94915 | |
| TNTVEEPLDLIRLSL | 11 | P62310 | |
| DPSLRDEILEVLLQV | 146 | P42356 | |
| EKEQLTPRETTFLEI | 131 | Q8WVF5 | |
| NADSQTLPLEIVERI | 376 | Q9Y5X9 | |
| TQEPLERAVSDLLAV | 96 | P12525 | |
| RISLDTPDFTDIVLQ | 341 | O75581 | |
| TPDFTDIVLQLEDIR | 346 | O75581 | |
| VLLRADREDIQVSTP | 461 | A6NHZ5 | |
| LEENVFSSPRALEVL | 336 | Q7L985 | |
| QVRFPTDTLQELLDV | 341 | Q8N8V2 | |
| QPVSAELLELDIREV | 106 | P36915 | |
| VEDQLQADVRPTLET | 651 | O75110 | |
| TLEEELALSRQATEP | 31 | Q8NAT1 | |
| NRVTLDLPIDLEEQT | 901 | Q9BZA7 | |
| EALPLLVRVIQSADS | 946 | O00410 | |
| EDLTPAQLTRRIQSL | 661 | O94988 | |
| TEVLVFELSPDRSLR | 391 | Q8IYI6 | |
| VEDLIISELRERFPS | 61 | O14732 | |
| EPSDVVNSLDLRVDI | 746 | P17301 | |
| VNSLDLRVDISLENP | 751 | P17301 | |
| LPLTDRVDSFNEEVR | 221 | P18084 | |
| IIRDPDELDRSFTSQ | 1101 | P16144 | |
| PGLTREVTQDDLDRI | 541 | O95402 | |
| EVRLTLSDPQQVTLD | 906 | P29375 | |
| LDSRNETLDPEQRVI | 41 | Q86WI3 | |
| LLSTLAEEPREQQEL | 876 | P29474 | |
| RAPTFLRELSDETVV | 7461 | Q5VST9 | |
| REEQPEFSLTLVALD | 201 | Q9Y5E5 | |
| LEDEINRTTAEDLPI | 621 | Q9UHC9 | |
| SPIREELVSSDELRQ | 346 | Q8N573 | |
| DREEAPEIFLVLTAT | 201 | Q9UN74 | |
| LPDSRDREDQLQTTE | 776 | Q9UN74 | |
| SEREAPSIEQRLQEV | 361 | Q86WN1 | |
| VRQQLTLPSALDTDR | 131 | Q8IUM7 | |
| DERIEIDAALLTSQP | 1026 | Q9BXP8 | |
| LNQVLDREEIPEFSL | 196 | Q9Y5E2 | |
| DREEIPEFSLTLTAL | 201 | Q9Y5E2 | |
| DVTDINDNRPELLLS | 336 | Q9Y5E2 | |
| LDLESRVPNSVLRFE | 96 | Q9P2J9 | |
| IQAPLEDEVTRNLSL | 246 | Q9P2J9 | |
| IEEFEQLQASRPDTR | 821 | Q3L8U1 | |
| DIRIDERTVSPFLQL | 231 | Q5W0U4 | |
| LPESNRSNIEVLRFE | 411 | Q8NFQ6 | |
| LELRETTFPDQVQDL | 1631 | Q96N67 | |
| SLETLEDIEENAPLR | 291 | Q8TDN4 | |
| EEVIVPESTNARFRL | 3596 | Q8TD57 | |
| RAAIELPSLEVLSDQ | 246 | Q9BQI3 | |
| LDTVIQRLEDTILSP | 21 | H7BZ55 | |
| LVDNQRSRLPVSLSE | 551 | Q9Y6R7 | |
| EQFIPSRRLDTEELS | 206 | P35790 | |
| TPSDLRNLDELVREI | 201 | Q99501 | |
| RPVEVLLNDDLIVST | 1336 | P01031 | |
| ESRVISQPDQTLEIL | 166 | P17707 | |
| QVITTERLDRENPLE | 2551 | Q8TDW7 | |
| VASVLNDPELSEVIR | 1301 | Q86UU0 | |
| TPDLRISIENSEEAL | 51 | Q9Y653 | |
| IEVSRLFLEPTQADI | 1891 | P08519 | |
| RRLPELAVDTELSQS | 886 | Q9P203 | |
| RSDTSQILEENIPVL | 86 | Q8TDM0 | |
| SDPIQEIRDLAEITT | 141 | Q9BS26 | |
| RPNVVLLLTDDQDEV | 46 | P15586 | |
| TVEVRTLDDRLLNIP | 246 | P59910 | |
| LPTTEEAEELERALQ | 646 | Q53TQ3 | |
| LERVRSQPLTNDDLV | 176 | Q4VXA5 | |
| DRATNRLLEPESEFI | 141 | Q9UJ99 | |
| PEELTRQAVRLEDNS | 456 | Q5T6L9 | |
| DLTELRQQPVASEDI | 416 | A6NE01 | |
| LQEEVEELLRLPSDF | 1076 | Q8TDG4 | |
| DIIPALSESVTQERR | 301 | Q9NQC7 | |
| IIQVTIPDDDNERLS | 846 | P78347 | |
| LESIRETAEEPLSIQ | 156 | Q8NFJ9 | |
| ETAEEPLSIQSLRFL | 161 | Q8NFJ9 | |
| TISPEQAIDSLRDLR | 161 | Q16667 | |
| LSVLPESTLFRLDQE | 551 | P51530 | |
| RLRTVLLDVTDPENV | 76 | Q9BPW9 | |
| QPFRLESLLTDDVEI | 3391 | Q8IVF4 | |
| DSLRLQPLDVIESDS | 621 | P51168 | |
| RIPSLVILDDESEAQ | 821 | Q9NZJ4 | |
| PRLLSSILEEQLDEE | 3971 | Q9NZJ4 | |
| VLTETPQDTIELNRL | 201 | P30260 | |
| ELTIPLAIENFLRES | 151 | Q8NEC7 | |
| VRLSEDAEPTVRTEL | 91 | Q9P1A2 | |
| EQLDFLRISDTEELP | 666 | Q93100 | |
| ETRTLFPVVLEQLDD | 466 | Q16363 | |
| LDINDEQTLPRLIEA | 486 | Q02241 | |
| TVPLEEQTELESERL | 636 | Q9H0X9 | |
| PALVEIDRSVENTLL | 561 | Q96PC5 | |
| TVVSADLLIDDRPDI | 166 | Q9NPB1 | |
| VANPEDTRSLEARII | 116 | P82914 | |
| DDLLINVIQDRSTPD | 101 | Q5HYW3 | |
| LDSTDQLEFTVEPRL | 256 | O75298 | |
| DVVLLEAREPLSSIN | 206 | Q5VWG9 | |
| VEALERDIVSRNPSI | 191 | Q9BW62 | |
| LLADVVLQPRLTDEE | 166 | Q10713 | |
| QLEPDLSEEVSARLR | 316 | Q9HC62 | |
| STEEELRQLLASLPQ | 206 | Q96JX3 | |
| TASLPRELTLQDVEL | 266 | Q13049 | |
| SQPEAQRELDVVLRT | 171 | Q8IYL2 | |
| IFDTDDRSQTILPLV | 281 | Q6NUP7 | |
| EDVFLLETDNPRTTL | 306 | Q99985 | |
| ASEVLRIQNILTEEP | 301 | P27169 | |
| TEEIATSIEPIRDFL | 541 | Q6UWJ1 | |
| PLRIELTDTTLEQVR | 496 | Q24JP5 | |
| RLPLQIEISDTELSQ | 516 | Q14DG7 | |
| VPLLEDTASRIDELF | 5241 | Q8WXH0 | |
| LQLLDTTEIENRPEF | 5656 | Q8WXH0 | |
| LPDLERAVTELTVIQ | 421 | Q6IEE7 | |
| EVPISLEVSQDRRAE | 576 | O15061 | |
| ILSTEEERTTLLPNE | 441 | Q6NT16 | |
| ATELVAEPNRRVLET | 176 | Q15345 | |
| PETFVQLDQRLSRLE | 541 | O14841 | |
| ETIFEEPRERNGTLI | 496 | Q9BWN1 | |
| RAEISELPSIVQDLA | 696 | P41250 | |
| LEPLLSRFTEEEELQ | 341 | O43272 | |
| IVTLRSVEDEERPFA | 671 | Q9H2Y9 | |
| PLLIQDEDSTRIERV | 1186 | Q13796 | |
| LEAAPRQRIELTFDE | 76 | Q8NC67 | |
| DDVLILPNRTVLVDT | 2761 | P08F94 | |
| TEPESVFALDVLRQR | 106 | O75683 | |
| RELQPSIIFIDEVDS | 431 | Q9UBP0 | |
| TAEIPVDLNTREVIR | 1816 | Q9P2P6 | |
| ELPETQRLQSELDVL | 446 | Q2KHM9 | |
| IRDSPTILQQVDETL | 136 | Q8WVF1 | |
| FILRLEDTDQTRVVP | 71 | Q5JPH6 | |
| RLQTRLQPEESTETL | 261 | Q8N0Z3 | |
| VERDIILDNPTLTLE | 586 | Q08188 | |
| LLFPESIRVDTRDQE | 211 | Q66K14 | |
| RQETDSIPLVDDIRF | 431 | Q969K4 | |
| IEVEDLPQFTTRSEL | 96 | Q96HQ2 | |
| ELLPQEQRSVESSLR | 36 | Q99828 | |
| NRRPEDQELESLSAI | 426 | P10645 | |
| VVLEDLSPLEARVTR | 26 | Q99788 | |
| PQDTERLVLTFVDRL | 531 | O75339 | |
| TRIEFTTRQLPDLED | 161 | Q7LFX5 | |
| VLALLELPEREVDNT | 416 | P42695 | |
| SFVILEPETNRELEA | 516 | Q9HAW4 | |
| ARDTLEQLTDLVLSP | 441 | Q9Y446 | |
| DNEIRATDLPERFQL | 286 | Q7KZ85 | |
| SLTPAEVEQRREQLE | 66 | Q15036 | |
| LEPRDEVVQAVLDST | 281 | Q5JU69 | |
| RDISLVPTRQEVEAE | 746 | Q9Y2H5 | |
| VDISNLEAALRAEEP | 871 | Q9Y2H5 | |
| EVDDILAAVRPTTRL | 176 | Q96I15 | |
| PRTSVFLEELNEAVR | 56 | Q9P2K2 | |
| ANPELILSEDRRSVQ | 296 | Q96F44 | |
| TQPFQRLLEEDVISI | 741 | Q8IZQ1 | |
| RLLEEDVISIESVSP | 746 | Q8IZQ1 | |
| LSRSTELIRQDFDVP | 576 | Q4G0A6 | |
| LVQDRLRPTAEETLE | 1836 | Q15772 | |
| LEVLPDRVATSRISD | 111 | Q9Y657 | |
| DERVSSLEVLPNRVA | 101 | Q5JUX0 | |
| EQDSVLPRRSLAELS | 161 | A6NCQ9 | |
| LESPRDLQFSEIRET | 3756 | P22105 | |
| AVTEQELLALDTIRP | 56 | A6NIH7 | |
| SEDFLLEAQVRDQPR | 116 | Q9H3S3 | |
| REFQSPLILDEDQAR | 486 | Q3KQV9 | |
| TSDLEIVNILERSPE | 151 | Q99551 | |
| LRITPTRLLEASENV | 16 | Q8TBZ2 | |
| SPDLELLLRSSQREE | 336 | Q9NQQ7 | |
| EEREFRAPTLASLEN | 351 | Q9UGP8 | |
| DNIELVDTFQTLEPR | 2041 | O95359 | |
| IETQERPRDVSSVEL | 1926 | P11277 | |
| EEERTRFQELLASPA | 191 | Q9NSI2 | |
| SLVPAAELLESRVID | 3116 | Q15149 | |
| RNLLVTIENDTPLEE | 216 | P98182 | |
| VFRLLTLDSEEVPEA | 161 | Q96SJ8 | |
| ELFVNRLDSVESVLP | 61 | Q99805 | |
| VLRSLEQEEPFDLSQ | 581 | Q8N895 | |
| VDSEDIPLNLSRELL | 391 | Q12931 | |
| QPDLVTIVDDLRLDI | 376 | Q9UPU5 | |
| ATRDVVLSRVPEQEE | 356 | Q9ULT0 | |
| PERLERTSVEVLDVQ | 956 | O60346 | |
| DRIPLQIVRAETELS | 16 | Q9UL62 | |
| ERVDRLSVSVTQLDP | 71 | Q92558 | |
| QSRPDALITDQEILR | 296 | Q9C0D7 | |
| TDEPVTRLNIQDVRE | 251 | Q96FK6 | |
| VELLRFLESLPEEEQ | 356 | P17480 | |
| QEERPELSESELTRL | 426 | P17480 | |
| PETVETILNLLDQDR | 51 | Q6XPR3 | |
| DTLENRIRTLSLEPE | 266 | P57768 | |
| RIRTLSLEPEESLDV | 271 | P57768 | |
| VRLSLEAIPDTVNLE | 306 | A5PLN9 | |
| VLIEFSLLRLENPDE | 106 | Q5T4S7 | |
| ASVLDVLTPDDVRIL | 996 | Q14679 | |
| EALIIQLLTEEASRP | 696 | Q9Y4E6 | |
| TSRTFRIEEIPLDQV | 966 | Q93009 | |
| RNDTIPVLLDIAERT | 206 | Q9HBA0 | |
| LTERREDFQDISVPV | 446 | O94782 | |
| SVSEERQLAVLTELP | 676 | Q15386 | |
| EIRTFEPRLLVQSIE | 266 | Q96JC1 | |
| AVELPREIQSLETSE | 521 | Q6UXF1 | |
| REDNIPQLEDVSRFL | 296 | P07101 | |
| ELQRLTASEPLTLEQ | 36 | Q9BTE0 | |
| PITRRDLFSQEIQLD | 26 | P52961 | |
| ETVLDTPEIQRVREN | 6096 | P20929 | |
| ELSEELSRRLQITPD | 306 | Q96PU5 |